Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
96%
OVERLAP
BY WEIGHT
302
# OF OVERLAPPING
HOLDINGS
VHT
417
HOLDINGS
78%
ALSO IN FHLC
FHLC
350
HOLDINGS
96%
ALSO IN VHT
SECTOR DRIFT (VHT minus FHLC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.6% | 13.1% | 13.1% |
|
JOHNSON & JOHNSON | 8.3% | 8.9% | 8.3% |
|
ABBVIE INC | 6.7% | 6.4% | 6.4% |
|
MERCK & CO. INC. | 4.8% | 5.1% | 4.8% |
|
UNITEDHEALTH GROUP INC | 5.1% | 4.7% | 4.7% |
VHT Overweight Relative to FHLC
|
ELI LILLY & CO | 0.5% |
|
UNITEDHEALTH GROUP INC | 0.4% |
|
ABBVIE INC | 0.3% |
|
MCKESSON CORP | 0.2% |
|
INTUITIVE SURGICAL INC | 0.1% |
 |
MEDTRONIC PLC | 0.1% |
|
CIGNA CORPORATION | 0.1% |
|
STRYKER CORP | 0.1% |
|
VEEVA SYSTEMS INC-CLASS A | 0.1% |
|
CARDINAL HEALTH INC | 0.1% |
VHT Underweight Relative to FHLC
|
JOHNSON & JOHNSON | -0.5% |
|
ROYALTY PHARMA PLC CLASS A | -0.3% |
|
MERCK & CO. INC. | -0.3% |
|
THERMO FISHER SCIENTIFIC INC | -0.2% |
|
BRISTOL-MYERS SQUIBB CO | -0.1% |
|
INSMED INC | -0.1% |
|
ALNYLAM PHARMACEUTICALS INC | -0.1% |
|
CRISPR THERAPEUTICS AG | -0.1% |
|
VERTEX PHARMACEUTICALS INC | -0.1% |
|
DEXCOM INC | -0.1% |